PREPRINT – © Copyright reserved to the author. Any reuse is strictly prohibited without written permission from the author. The author accepts absolutely NO liability of any sort for using the data in this preprint or whatever consequences of such use.
Amicus Plato, sed magis amica veritas: There is a reproducibility crisis in COVID-19 Computational Fluid Dynamics studies
Khalid M. Saqr, Ph.D. (ORCID: 0000-0002-3058-2705)
Innovation Hub, Arab Academy for Science, Technology and Maritime Transport, Al-Alamein Campus, 51718, EGYPT
Email: k.saqr@aast.edu
ABSTRACT
There is overwhelming evidence on SARS-CoV-2 Airborne Transmission (AT) in the ongoing COVID-19 outbreak. It is extraordinarily difficult, however, to deduce a generalized framework to assess the relative airborne transmission risk with respect to other modes. This is due to the complex biophysics entailed in such phenomena. Since the SARS outbreak in 2002, Computational Fluid Dynamics (CFD) has been one of the main tools scientists used to investigate AT of respiratory viruses. Now, CFD simulations produce intuitive and physically plausible colour-coded results that help scientists understand SARS-CoV-2 airborne transmission patterns. In addition to validation requirements, for any CFD model to be of epistemic value to the scientific community; it must be reproducible. In 2020, more than 45 published studies investigated SARS-CoV-2 airborne transmission in different scenarios using CFD. Here, I systematically review the published CFD studies of COVID-19 and discuss their reproducibility criteria with respect to the CFD modeling process. Using a Weighted Scoring Model (WSM), I propose a novel reproducibility index for CFD simulations of SARS-CoV-2 AT. The proposed index (0≤Rj≤1) relies on three reproducibility criteria comprising 10 elements that represent the possibility of a CFD study (j) to be reproduced. Frustratingly, only 3 of 23 studies (13%) achieved full reproducibility index (Rj≥0.9) while the remaining 87% were found generally irreproducible (Rj<0.9). Without reproducible models, the scientific benefit of CFD simulations will remain hindered, fragmented and limited. In conclusion, I call the scientific community to apply more rigorous measures on reporting and publishing CFD simulations in COVID-19 research.
Keywords: COVID-19, SARS-CoV-2, airborne transmission, computational fluid dynamics, reproducibility
INTRODUCTION
To the date of writing this article, COVID-19 pandemic outbreak has resulted in 1.6 million deaths and a historic crash of financial markets[1] leading to major fractures in the world economy[2]. This pandemic challenges our healthcare systems, economic models and social lifestyle[3]. Many countries refuged to enforcing nationwide curfew[4], travel ban and quarantine[5], social distancing and obligatory use of face masks[6] as measures to mitigate the outbreak. Despite few earlier controversies[7, 8], now there is a widely accepted theory among scientists now proposing that airborne transmission (AT) is a major infection scenario of COVID-19[9-11]. Few days after the WHO declared COVID-19 a pandemic[12], a study[13] published in New England Journal of Medicine demonstrated the possibility of SARS-CoV-2 AT experimentally. The study compared the stability of SARS-CoV-1 and SARS-CoV-2 in aerosols and on surfaces. It was evidently shown that SARS-CoV-2 has an aerosol stability similar to SARS-CoV-1 and remains infectious in aerosols for hours. SARS-CoV-2 infected patients were shown to exhibit high viral loads in the upper-respiratory tract[14], manifesting the possibility of producing highly infectious aerosols even from asymptomatic patients[15]. Infectious aerosols are often categorized according to the droplet particle size. During a sneeze or a cough, aerosols of respiratory tract fluid are produced containing large particles (i.e. droplets) typically greater than 5 µm in diameter. These particles impact directly on a susceptible individual. On the other hand, a susceptible individual could possibly inhale microscopic aerosol particles consisting of the residual solid components of evaporated respiratory droplets, which are small enough (<5 µm) to remain airborne for hours[16]. Even during speech, thousands of oral fluid droplets that constitute AT and COVID-19 infection risk[17]. It was also established that infectious SARS-CoV-2 RNA is persistent in aerosols collected in the vicinity of infected individuals with particles of small and large sizes[18]. Jin et al[19] showed that SARS-CoV-2 positive air samples can be collected in ICU room for four days after the residing patient tested negative. Guo et al[20] collected positive samples from ICU air as far as 4 m from patients. Despite rapid air changing in airborne infection isolation rooms (AIIRs), Chia et al[21] showed that SARS-CoV-2 RNA can be detected in air samples with particle sizes of
RELEVANCE OF CFD MODELS IN SARS-2002 OUTBREAK
SARS-CoV-2 is an enveloped virus with a diameter of
PURPOSE, SCOPE AND REVIEW APPROACH
The purpose of this article is to promote better reporting practice of CFD studies related to COVID-19 research and biomedical research at large. The scope is limited to the concept of reproducibility in CFD practice. The establishment of any CFD study requires proper level of verification, validation and reproducibility otherwise, it would not be possible to confirm the study’s conclusion[35]. In COVID-19 air transmission research, CFD models represent the interface between the biomedical and managerial aspects of the COVID-19 infection control problem. The rapid, aggressive and mutating COVID-19 outbreak compels certain level of diligence to support balanced and effective decision making strategies of infection control. The scope of reproducibility here refers to the minimum level of details at which a CFD model could be reproduced with a quantifiable measure of error or deviation.
Similar to SARS-CoV-1, the importance of CFD in investigating SARS-CoV-2 AT is driven by its parametrization capability that identifies AT patterns of virtually any given scenario. Each scenario reveals aerodynamic aspects specific to the settings, physical models and validation data of the CFD simulation. To compile a comprehensive resource of COVID-19 CFD studies and their reproducibility criteria, a systematic review of the CFD studies is conducted and discussed. The search engine Scopus was used to identify the reviewed studies. On December 23rd 2020, a search in TIT-ABS-KEY field yielded 49 studies with the search string: TITLE-ABS-KEY ( "computational fluid dynamics" OR "CFD" ) AND TITLE-ABS-KEY ( "Covid-19" OR "SARS-CoV-2" OR "Coronavirus" ) AND ( LIMIT-TO ( PUBYEAR , 2021 ) OR LIMIT-TO ( PUBYEAR , 2020 ) OR LIMIT-TO ( PUBYEAR , 2019 ) ). The studies were obtained, reviewed to identify the main corpus of this review. A total of 23 studies were found to report formal and conclusive CFD results. The studies were then classified according to transmission scenario, solver, computational model, physics, and settings of each respective CFD model. The studies were classified into three sets. Set (A)[36-43] represents the studies conducted on COVID-19 in healthcare facilities such as hospital wards and care rooms. Set (B)[44-52] represents the studies conducted on SARS-CoV-2 AT in respiratory scenarios such as in nasopharyngeal and pulmonary spaces. Finally, set (C)[53-58] represents the studies conducted on COVID-19 in generic spaces and buildings.
Bibliometric insight
By subject area, 24% of the studies were published in engineering journals while the publications in medicine, chemical and environmental engineering were 16%, 12% and 11%, respectively. It must be noted that many studies are published under more than one subject area. The 49 studies received 117 citations in total achieving a Scopus h-index value of 5 until the December 23rd. The studies published under medicine research area received 52 citations (44% of the total citation count). Eight of the 23 CFD studies received 86 citations (73.5% of the total citation count). By article type, the 49 studies were classified into 80% articles, 6% reviews and 14% of other article types. Overall, self-citations constituted only 8.5% of the total citation count. Figure 1 shows a graphical representation of bibliometric data. The supplementary materials include tabulated data of the citation count of the 49 studies.
Figure 1. Bibliometric insight into the COVID-19 CFD published studies showing (a) contributions by subject area, (b) by publication type and (c) h-graph indicating h-index value of 5 and (d) percentage of cited CFD studies compared to the selected corpus.
METHOD: A REPRODUCIBILITY INDEX FOR CFD MODELS OF COVID-19
There are three criteria of reproducibility that any fluid dynamicist with firsthand experience in modern CFD software needs to address in order to replicate a simulation case[59, 60]. The first criterion deals with the numerical formulation of the model, the second one deals with physical formulation and the third deals with the parametric framework of the simulation being reproduced. The elements of each reproducibility level are detailed in table 1. In order to evaluate the 23 CFD studies, a novel reproducibility index is proposed. The index is developed based on the weighted scoring model (WSM) commonly used in engineering project management. The importance of each element relevant to COVID-19 research is assigned a numerical weight
where
Table 1. Levels and elements of CFD simulation reproducibility process
Reproducibility Level | Elements |
|
|
|
|
|
|
Table 2. COVID-19 CFD reproducibility elements and their corresponding WSM weights
| Element | ||
Numerical formulation | Solver | 10 | 1 if the solver was reported 0 if the solver was not reported |
Model Dimensions | 20 | 1 if the dimensions were reported 0 if the dimensions were not reported | |
Grid resolution | 10 | 1 if the grid resolution was reported 0 if the grid resolution was not reported | |
Physical formulation | Turbulence model | 10 | 1 if the turbulence model was reported 0 if the turbulence model was reported |
Aerosol model | 10 | 1 if the aerosol model was reported 0 if the aerosol model was not reported | |
Reynolds number | 5 | 1 if the Reynolds number was reported 0 if the Reynolds number was not reported | |
Initial and Boundary conditions | 20 | 1 if the initial and boundary conditions are FULLY reported 0 if any initial and/or boundary conditions are missing | |
Particle density | 5 | 1 if the particle density was reported 0 if the particle density was not reported | |
Independent variables | Aerosol particle diameter | 5 | 1 if the particle diameter is reported 0 if the particle dimeter is not reported |
Validation | 5 | 1 if the study reports validation 0 if the study does not report validation | |
|
RESULTS AND DISCUSSION
The distribution of
Infection control in healthcare facilities is of crucial importance in managing COVID-19 outbreak. Set (A) [36-43] comprises CFD studies of different AT scenarios in hospitals and healthcare facilities. The computational domain in these studies always represent the air flow around aerosol source of particular settings that represent SARS-CoV-2 AT. Grid resolution ranged from
Figure 2. Reproducibility index
Figure 3. Normal distribution of